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To understand skin aging, studies need to examine the major cutaneous compo-
nents, including keratinocytes, fibroblasts, and vascular endothelial cells. Cellular
senescence is accelerated by diverse stresses, and various factors involved in cell
senescence have been reported. For example, telomere uncapping, DNA damage,
oxidative stress, oncogene activation, nutritional deficiency, growth factor defi-
ciency, and mitochondrial damage all play roles.1,2 Protein expression is altered in
aging cells and has an important role in the pathogenesis of aging. The expression
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Purpose: Endothelial cells maintain the homeostasis of blood, which consists of
plasma and cellular components, and regulate the interaction between blood and
the surrounding tissues. They also have essential roles in vascular permeability, the
circulation, coagulation, inflammation, wound healing, and tissue growth. The
senescence of endothelial cells is closely related to the aging of the adjacent tissues
and to age-related vascular disease. Recently, the expression of moesin was found
to be decreased in elderly human dermal microvascular endothelial cells
(HDMECs), and an association between moesin and senescence has been
suggested. This study examined the functional role of moesin in cellular
senescence. Materials and Methods: To study the effects of decreased moesin
expression on cellular senescence and metabolism, HDMECs were transfected
with short hairpin-RNA (shRNA) lentivirus to silence moesin gene expression. In
addition, specimens from young and old human skin were stained with anti-
moesin and anti-p16 antibodies as an in vivo study. Results: Using shRNA-
lentivirus, moesin knock-down HDMECs developed characteristics associated
with aging and expressed senescence associated-beta-galactosidase during early
passages. They also showed increased p16 expression, decreased metabolic
activity, and cell growth retardation. Human skin tissue from elderly persons
showed decreased moesin expression and increased p16 expression. Conclusion:
These findings suggest that there is a functional association between moesin
expression and cellular senescence. Further study of the functional mechanism of
moesin in the cytoskeleton and cellular senescence is needed. In addition, this
study provides a useful model for developing anti-aging treatments.
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INTRODUCTION
of insulin-like growth factor binding protein-5, neurofila-
ment subunit L, adenosine A2A receptor, plasminogen
activator inhibitor-1, intercellular adhesion molecule-1,
p16, and p27 is altered in senescent endothelial cells.3-6
The vascular endothelial cells between blood and tissues
maintain homeostasis through their interaction with plasma.
They have the capacity to generate new blood vessels and to
maintain their integrity, and their normal function is
important for inflammatory reactions, coagulation, wound
healing, and tissue growth.7,8 The senescence of vascular
endothelial cells is associated with atherosclerosis,
hypertension, congestive heart failure, sepsis, diabetes,
thrombotic thrombocytopenic purpura, systemic sclerosis,
systemic lupus erythematosus, and the metastasis of
cancer, as well as the intrinsic aging of the skin.9-18 How-
ever, the precise mechanisms of senescence have not been
elucidated. The growth, aging, and apoptosis of vascular
endothelial cells can be induced or suppressed in response
to stimulation by serum factors or adjacent cells. Since most
pathophysiological conditions occur at the level of the
microvasculature, endothelial cells are very suitable as a
research model for the aging of skin, prompting us to use
these cells. Previously, our studies have shown that kinetin,
epigallocatechin-3-gallate, all-trans retinoic acid, and sel-
enium have anti-aging effects on cultured human dermal
microvascular endothelial cells (HDMECs).19,20 Using these
materials, several proteins suspected of being aging-related
proteins were detected in proteomic maps of HDMECs ob-
tained before and after exposure to anti-oxidants.20 Moesin,
Rho guanosine-5’-diphosphate-dissociation inhibitor, and
actin played significant roles, especially moesin.
Moesin is an ezrin/radixin/moesin (ERM) protein and
belongs to the band 4.1 superfamily. Members of the band
4.1 superfamily share a 300-amino-acid domain called the
4.1 ezrin, radixin, and moesin (FERM) domain.21-23 Moesin
acts as a cytoskeleton protein connecting cell membrane
proteins and actins located underneath the cell membrane. It
maintains cell polarity or integrity and regulates the func-
tions of cell membrane proteins. It also has a signal trans-
duction function in addition to its role in remodeling the cy-
toskeleton.24-26 Recently, it was reported to be associated with
conjugation between T cells and antigen-presenting cells,
leukocyte diapedesis, and endothelial cell migration and
permeability.27-29 It has been suggested as a potential progno-
stic marker of thyroid cancer, renal cell carcinoma, and pan-
creatic adenocarcinoma.30-32 Ezrin induces apoptosis via Fas,33
and Gα13 activation rescues moesin-depletion-induced apo-
ptosis in F9 teratocarcinoma cells.34 These findings suggest
that ERM proteins are closely related to apoptosis and aging.
To examine the functional role of moesin in skin aging,
we examined the effect of moesin on aging and metabolic
function using a short hairpin-RNA (shRNA) lentivirus to
suppress moesin expression in subcultured HDMECs. In
addition, the difference in moesin and p16 expression in
young and old skin tissues was examined.
HDMEC culture
Human dermal microvascular endothelial cells were pur-
chased from Cambrex (Walkersville, MA, USA). HDMECs
were prepared and treated in a tissue incubator with 0.1%
gelatin, using microvascular endothelial cell medium-2
(Cambrex) containing human epidermal growth factor,
hydrocortisone acetate, vascular endothelial growth factor,
human fibroblast growth factor-B, gentamicin, ampho-
tericin B, 5% fetal bovine serum, R3-insulin growth factor-
1, and ascorbic acid. They were subcultured serially from
passage 5 to 25 at 37˚C in a CO2 incubator.
Suppressing moesin expression with a shRNA-lentiviral 
vector
Preparation of shRNA-lentiviral vector targeting moesin
A shRNA-lentiviral vector targeting moesin was prepared
by inserting a synthetic double-stranded oligonucleotide
(5’-GCAGCGCATTGACGAATTTGA-3’) in the EcoRI -
XbaI restriction enzyme site of shLenti2.4R lentiviral vector
(VectorCore A, Daejeon, Korea). The shLenti2.4R lentiviral
vector was designed to express shRNA at the human U6
promoter and to express red fluorescent protein (RFP)
from the hCMV promoter. A shLenti2.4R lentiviral vector
with a scrambled shRNA (5’-AATCGCATTAGCGTAT
GCCGTT-3’) insert was used as the control vector. The
scrambled shRNA lacks homology with any mammalian
mRNA sequence.
shRNA-lentiviral vector production
The recombinant lentiviral vector was manufactured by
VectorCore A. 293T cells were transfected with transfer
vector, VSV-G expression vector, and gag-pol expression
vector in a 1 : 1 : 1 ratio using LipofectAMINE PLUS (Invi-
trogen, Carlsbad, CA, USA). The supernatant of the culture
medium containing the lentiviral vector was collected 48 h
after transfection and was refined using 0.45-µm membrane
filters (Nalgene, Rochester, NY, USA).
Transfection of shRNA-lentiviral vector to HDMECs
The HDMECs were mixed with 1 mL of shRNA-lentiviral
vector without culture medium on a plate. After adding 8 µg
of Polybrene (hexadimethrine bromide, Sigma, St. Louis,
MO, USA), the plate was shaken and cultured at 37˚C in
5% CO2 for 6-8 h.
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MATERIALS AND METHODS
Confirmation of HDMEC transfection with the expression
of RFP
To confirm whether the HDMECs were transfected with
shRNA-lentiviral vector, red fluorescent protein (RFP)
expression was examined in HDMECs at passages 6, 10,
and 20 using fluorescence microscopy.
Phase-contrast microscopic examination
Phase-contrast microscopy (Olympus, Tokyo, Japan) was
used to confirm the senescence of HDMECs and to examine
the morphologic changes of transfected HDMECs accord-
ing to the number of serial passages.
Senescence-associated-β-galactosidase staining
The modified senescence-associated-β-galactosidase (SA-
β-gal) assay was used to compare senescence according to
the number of serial passages of untreated HDMECs,
control vector-treated HDMECs, and moesin-knock-down
HDMECs. The cells were washed twice with phosphate-
buffered saline (PBS), fixed in 3% (v/v) formaldehyde for
3 min at room temperature, washed again in PBS, and
incubated for 12 h with 500 µL of β-GAL solution contain-
ing 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal), 5
mM potassium ferrocyanide, 150 nM NaCl, and 2 mM
MgCl2. The cells were viewed and photographed with a
light microscope fitted with a digital camera.
Measuring the doubling time and doubling level of the 
cumulative cell population
To obtain lifespan curves, cell cultures were serially pas-
saged until the end of their proliferative capacity in vitro
and the population-doubling levels were determined. The
time required for 1×105 HDMECs to double was regarded
as the doubling time.
Reverse transcriptase-polymerase chain reaction (RT-
PCR)
Extracting total RNA
Virus-untreated HDMECs, HDMECs over passage 25,
control vector-treated HDMECs, and moesin-knock-down
HDMECs were serially cultured. Total RNA was isolated
using an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA)
according to the manufacturer’s instructions. The RNA
concentration was measured at 260 nm using an UV-1601
PC spectrophotometer (Shimadzu, Kyoto, Japan).
First strand cDNA synthesis
cDNA was synthesized from 1 µg of extracted total RNA
using AccuPower RT PreMix (Bioneer, Seoul, Korea) and
a PCR system 2700 (Applied Biosystems, Singapore, Singa-
pore).
PCR of moesin and p16
Polymer chain reaction amplification was carried out using
1 µg of cDNA as the template in 20 µL of PCR mixture
containing 1 µL of 20 pmole primer with AccuPower RT
PreMix (Bioneer). The PCR fragments were visualized on
2% agarose gels containing 5 µg/mL ethidium bromide. The
same amount of actin was used as a standard for quan-
tification. The moesin primers were 5’-CCACCATGCC-
CAAAACGATC-3’ (forward) and 5’-GGTGCCCATTA-
CATAGACTC-3’ (reverse). The p16 primers were 5’-
AGCATGGAGCCTTCGGCTGAC-3’ (forward) and 5’-
CTGTAGGACCTTCGGTGACTGAT-3’ (reverse).
Western blot analysis
Immunoblotting was used to examine the moesin and p16
expression. Cells were transferred to a microcentrifuge
tube and centrifuged for 10 min at 10,000 × g and 4˚C. The
supernatant was collected, and all of the supernatant was
used as the cell lysate. After sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE), the proteins
were transferred to an nitrocellulose (NC) membrane in a
container filled with transfer buffer solution for 2 h at 400
mA and 10-15 V. The membrane was blocked with 5%
blotting grade non-fat dry milk (Bio-Rad Laboratories,
Hercules, CA, USA) for 60 min. Primary antibodies to
moesin, p16, and actin (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) were diluted to 200 µg/mL in blocking
solution and added to the membranes, and the mixture was
incubated for 60 min. Antibody to horseradish peroxidase
(HRP; Santa Cruz Biotechnology) diluted to 1 : 2,000 in
blocking buffer solution was added as the secondary
antibody, and reacted with the primary antibody for 60
min. The membrane was washed three times with TBST
buffer solution for 5 min, and stained with 3,3,5,5-
tetramethylbenzidine.
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide] assay
The tetrazolium salt MTT was used to compare the
cellular metabolic capacities. Each well of a 96-well plate
was seeded with 1×105 HDMECs and preincubated at
37˚C in a CO2 incubator. The culture medium was removed
and the cells were incubated for 3 h with 200 µL of 0.5
mg/mL MTT (Boehringer, Mannheim, Germany). Meta-
bolically active cells reduce the dye to purple formazan.
The formazan crystals dissolved with 200 µL of dimethyl
sulfoxide (DMSO; Sigma), and the absorbance was measur-
ed on an ELISA reader (Bio-Rad Laboratories), using a refer-
ence wavelength of 630 nm and a test wavelength of 570 nm.
Tissue biopsy
To examine the expression of moesin and p16 in skin
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tissues, biopsies of the prepuce of neonates and the normal
abdominal skin of a 10-year-old child and an 86-year-old
adult were obtained. The neonatal prepuce was obtained
from circumcision, and the abdominal skin was obtained
with a 3-mm punch. The specimens were stored in Tissue-
Tek (Sakura Finetechnical, Tokyo, Japan) at -70˚C.
Immunohistochemical staining
The stored tissues were cryosectioned at 6 µm and attached
to silane-coated slides (Muto Pure Chemicals, Tokyo, Japan).
They were fixed in acetone for 15 min and washed with PBS.
Immunohistochemical staining was performed using the
Histostatin-DS kit (Zymed Laboratories, San Francisco, CA,
USA). To suppress nonspecific binding, the samples were
placed in a blocking solution for 10 min. Mouse anti-human
moesin monoclonal antibodies (GeneTex, San Antonio,
TX, USA) diluted 1 : 25 with PBS containing 5% bovine
serum and anti-human CD31 monoclonal antibodies (BD
Biosciences, San Jose, CA, USA) were used and incubated at
4˚C. The biotinylated secondary antibody was incubated for
10 min at room temperature. Streptavidin alkaline phospha-
tase (AP) conjugate was incubated for 10 min and nitroblue
tetrazolium solution (NBT) was used as a substrate for the
chromogen. For double immunohistochemical stains, double
staining enhancer solution was added and treated for 30
min at room temperature. This procedure was then repeated
with streptavidin horseradish peroxidase (HRP) instead of
AP conjugate and 3-amino-9-ethylcarbazole (AEC) solu-
tion was used as the substrate for the chromogen.
Confirming the infection of HDMECs by shRNA-
lentivirus
At passage 6, HDMECs were transfected with shRNA-
lentivirus, which knocked-down moesin expression, and
RFP expression was examined to confirm whether the
HDMECs had been transfected by the viral vector. Control
vector-treated HDMECs and shRNA-lentivirus-treated
HDMECs continuously showed RFP expression through
passages 10 and 20 (Fig. 1).
Correlation between moesin expression and the 
senescence of moesin knock-down HDMECs
Contrast microscopic findings
Using contrast microscopy, moesin knock-down HDMECs
were compared with virus-untreated HDMECs, HDMECs
at passages higher than passage 25, and control vector-
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RESULTS
Fig. 1. Confirming the infection of HDMEC by shRNA-lentivirus. Control vector-treated HDMECs and shRNA-lentivirus-treated HDMECs showed
RFP expression at p6, p10, and p20. HDMEC, human dermal microvasular endothelial cell; shRNA, short hairpin-RNA; CTR, control; CTR-V, control-
virus; RFP, red fluorescent protein.
CTR CTR-V Moesin-V
p6
p10
p20
treated HDMECs. A smaller degree of change in cell size
and morphology was detected between passages 6 and 20
in virus-untreated HDMECs and control vector-treated
HDMECs compared to moesin knock-down HDMECs at
early and late passages. By contrast, moesin knock-down
HDMECs showed the characteristics of aging, i.e., they
were large, flat, and stellate, beginning at the early stage of
passage 6.
Comparison of the aging level of HDMECs by the 
SA-β-gal assay
Control vector-treated HDMECs stained with SA-β-gal
were detected at passage 12. Moesin knock-down HDMECs
from the early stage of passage 6 were stained blue with
SA-β-gal. HDMECs at late passages higher than passage
25 stained blue in all serial subcultures (Fig. 2).
Growth retardation of moesin knock-down HDMECs
The growth of HDMECs was observed through lifespan
curves over time in the cultures. Within the culture period,
all HDMEC cultures showed an initial proliferation phase
and late growth retardation phase. In comparison with
control vector-treated HDMECs, the doubling time of
moesin knock-down HDMECs was delayed by 3 h at
passage 6 and 10 h at passage 22 (Fig. 3A). The doubling
level of the cumulative cell population in moesin-knock-
down HDMECs was much less than that in virus-untreated
HDMECs (Fig. 3B).
The expression of moesin and p16 protein and RNA in 
moesin knock-down HDMECs
The expression of moesin and p16 in cells was observed
using RT-PCR and Western blotting. Moesin knock-down
HDMECs expressed less moesin RNA than control vector-
treated HDMECs (Fig. 4A). In addition, the RNA expres-
sion of p16 in HDMECs at late passages and moesin knock-
down HDMECs was higher than that in control vector-
treated HDMECs (Fig. 4B).
In applying Western blotting, reduced expression of
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p22
Moesin-V CTR-Aged CTR-V Moesin-V CTR-Aged
Fig. 2. Comparison of senescent level in HDMEC transfected with shRNA-
lentivirus during subculture. Control vector-treated HDMECs without moesin
knock-down (CTR-V) from passage 12, moesin knock-down HDMECs (Moesin-
V) from passage 6, and HDMEC at over passage 25 (CTR-Aged) were stained as
blue with SA-β-gal staining. HDMEC, human dermal microvasular endothelial
cell; SA-β-gal, senescence-associated-β-galactosidase.
Fig. 3. Doubling time and doubling level of cumulative cell population. (A) The doubling time of Moesin-V group was longer than those of CTR-V group at passage 6 to 22.
(B) Doubling level of Moesin-V group was much less than that of CTR or CTR-V group. Error bars indicates standard deviations. These experiments have been
performed in a pair three times. 
A B
moesin and higher expression of p16 were observed in
moesin knock-down HDMECs, compared to control vector-
treated HDMECs (Fig. 4C).
Reduction of cellular metabolic activity
The MTT assay was performed in HDMECs at passage 20
to compare cell metabolic activity. Compared with control
vector-treated HDMECs, cellular metabolic activity dec-
reased in HDMECs at passage 39 and moesin-knock-down
HDMECs (p = 0.012 and 0.016, respectively) (Fig. 5).
Immunohistochemical staining of moesin, p16, and 
CD31 of skin tissues
The neonatal prepuce and the skin of the 10-year-old child
stained well with moesin, whereas the skin of the 86-year-
old adult did not stain. Conversely, cells stained with p16
were not detected in the neonatal prepuce or the skin of the
10-year-old child, while the skin of the 86-year-old con-
tained many cells stained with p16 (Fig. 6A). To exclude
the influence of the distribution of blood vessels between
the abdominal skin of the child and elderly adult on staining
with moesin and p16, double staining with moesin/CD31
and with p16/CD31 was performed. The abdominal skin
of the 10-year-old child and 86-year-old adult showed
comparable CD31-positive cells and tissues (Fig. 6B).
With aging, the function of organs decreases gradually
with cellular senescence. The replicative senescence of cells
resulting in the loss of replication capacity and a change in
the function and morphology of cells may be a key to
research on the pathophysiology of aging.35
Ezrin, radixin, and moesin constitute the ERM protein
family. ERM proteins are highly conserved throughout
evolution. More than 75% identity is observed in the FERM
domain and F-actin binding site of vertebrates (ezrin,
A Functional Role of Moesin in Cellular Senescence
Yonsei Med J   http://www.eymj.org    Volume 51   Number 3   May 2010 443
DISCUSSION
CTR-Aged CTR-Aged
p6
p8
p10
p12
p14
p16
p18
p20
Moesin-V Moesin-VCTR-V CTR-V CTR-Aged CTR-Aged
p6
p8
p10
p12
p14
p16
p18
p20
Moesin-V Moesin-VCTR-V CTR-V
CTR-V CTR-V
Moesin
p16
p14
Actin
CTR-Aged
(p33)
CTR-Aged
(p33)
Moesin-V Moesin-V
Fig. 4. Expression of moesin/p16 RNA and protein. (A) Moesin RNA expression in Moesin-V group and CTR-Aged group was lower than that in CTR-V group. (B) In
comparison with CTR-V group, CTR-Aged and Moesin-V groups showed higher RNA expression of p16. (C) Applying Western blotting, reduced expression of moesin
and higher expression of p16 were observed in Moesin-V group, compared to CTR-V group at passage 14. Left panels, autoradiographs of mRNA or protein levels; right
panels, relative amounts of mRNA or protein as estimated by an imaging analyzer. The values obtained were normalized by β-actin mRNA or protein content. Error bars
indicates standard deviations. These experiments have been performed in a pair three times. 
Fig. 5. Comparison of cellular metabolic activity. Cellular metabolic activity was
measured by MTT assay (48 hours). Cellular metabolic activity significantly
decreased in CTR-Aged group (passage 39) and Moesin V group compared to
CTR-V group (*p = 0.016, **p = 0.012). Mann-Whitney U-test was performed for
statistical analysis. Error bars indicates standard deviations. These experiments
have been performed in a pair three times.  
A B C
radixin, and moesin), Drosophila (Dmoesin), and C. elegans
(ERM-1).21,22 ERM proteins are essential for the
morphogenesis of the apical domain of different epithelial
cell types and regulate the functions of membrane
proteins.23,24,32 Ezrin is part of a complex that regulates the
Na+/H+ exchanger NHE3 in intestinal and renal brush
border microvilli36 and influences transport through cellular
membrane proteins.37 Dmoesin in Drosophila has a role in
the physiological functions of photoreceptors by interacting
with transient receptor potential (TRP) protein.38 Phago-
some maturation in macrophages and dendritic cells
depends on the activation of Rho via Rho kinase on ERM
proteins,39 and ERM proteins are important downstream
and upstream effectors of Rho GTPase, which is involved
in phagosome maturation and phagocyte movement toward
a dying cell.27,40 Few studies have examined the role of
moesin in cellular senescence, although the functional role
of moesin in cellular aging has been suggested from a
number of reports, which have found that ERM protein
induces Fasmediated apoptosis,33 and that the apoptosis of
cancer cells was induced by the decrease in moesin expres-
sion.34 Therefore, we characterized the function of moesin
by knocking out the moesin gene using shRNA.
RNA interference (RNAi) has become a widely used
technique for silencing gene expression. Successful appli-
cation of RNAi in mammalian cells depends on knocking-
down targeted transcripts and the effective intracellular deli-
very of either preformed short interfering RNAs (siRNAs)/
shRNAs or vector expressing si/shRNAs. Chemically
synthesized siRNAs are incorporated into the RNA-induced
silencing complex and the delivery results in sequence-
specific silencing of the expression of the corresponding
gene.41 RNAi can also be induced by the endogenous
expression of shRNAs, which are structurally related to a
highly conserved class of small RNAs known as micro-
RNAs (miRNAs) that mediate RNAi through a translatio-
nal inhibition mechanism.42 We used shRNAs for RNAi
because knock-down by siRNAs was not maintained during
the next passage. In contrast, we confirmed that knock-
down by shRNA-lentiviral vector was maintained until
passage 22 using RFP expression.
Contrast microscopy and the SA-β-gal assay were used
to assess the senescence of vascular endothelial cells. SA-
β-gal staining is widely used as a marker of senescence and
its usefulness has been reported in human vascular endoth-
elial cells, keratinocytes, fibroblasts, and smooth muscle
cells.43,44 Nonetheless, we did not perform the SA-β-gal assay
in tissue specimens because it has been reported that SA-β-
gal stains have low usefulness in vivo.45 The early appear-
ance of senescent cells was observed in moesin knock-
down HDMECs using contrast microscopy and SA-β-gal
staining. These cells were clearly different from the virus-
untreated HDMECs. The HDMECs treated with scrambled
shRNA-lentivirus also showed some changes of senescence.
These might have been induced by the virus itself or the
reagents used during viral transfection.
The doubling time of moesin knock-down HDMECs
was prolonged and growth retardation was detected in the
early phase in the life span curve. In addition, cellular met-
abolic activity decreased in moesin knock-down HDMECs.
These findings show that moesin knock-down makes
HDMECs senescence not only morphologically but also
functionally, and that moesin is a potential biomarker of
cellular aging of the skin.
Until now, the suggested aging mechanisms of normal
cells have included cellular proliferation, oxidative stress,
DNA damage, shortening of the telomere related to tumor
suppressor cascades, p16INK4A, and the ARF-p53 path-
way.46,47 It has been reported that cellular senescence pro-
gresses via p16 activation in response to oxidative stress or
telomere shortening rather than the ARF pathway.1,48 We
showed that p16 expression increased with cell aging, but
further studies need to examine whether telomere shorten-
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CTR Moesin p16
Age 1
Age 10
Age 86
CTR Moesin/CD31 p16/CD31
Age 10
Age 86
Fig. 6. Immunohistochemical staining of moesin and p16. (A) Immunohistoche-
mical staining of moesin and p16 was performed on the neonatal prepuce (Age
1) and the skin of the 10-year-old child (Age 10) and the 86-year-old adult (Age
86). Moesin was stained well as pink or brown in Age 1 and Age 10, on the other
hand, moesin was not detected well in Age 86. In contrast, p16 stained cells
were not detected well in Age 1 and Age 10 and numerous p16 stained cells
were observed in Age 86. (B) Comparable CD31 positive cells and tissues were
observed at double staining of moesin/CD31 and p16/CD31 between Age 10 and
Age 86. Double stained cells were observed as purple.
A
B
ing is associated with p16 and whether moesin is associated
with p19ARF and the p53 pathway via direct DNA. It has also
been reported that oxidative stress activates p16 via the
stress-activated protein kinase family, p38-MAPK;49
therefore, a study of p38-MAPK is needed to determine
whether moesin is related to the oxidative stress associated
pathway. The mitochondria play a major role in the pro-
duction of reactive oxygen species, and the accumulation
of mutated mitochondrial DNA has also been proposed as
a cause of cellular aging.2,50 We also need to study the asso-
ciation between moesin and mitochondria in the cell cycle
and senescence.
Cell senescence or apoptosis is closely related to the cell
cycle: if cellular senescence occurs, G1 arrest occurs, and
the G1-specific cyclin D1 or cyclin E1, pRB, p16, p21, and
p27 undergo change.6 p16 maintains Rb in its hypophos-
phorylated form and hypophosphorylated Rb suppresses
E2F activation and CDK4/6. Consequently, p16 induces
cell cycle arrest.51,52 Based on the increased p16 expression
in cell senescence, we postulate that the cellular aging
caused by moesin knock-down is associated with p16,
because p53 and p21 are involved in aging through mecha-
nisms involving DNA damage. Since p16INK4A expression is
directly correlated with the chronological aging of human
skin in vivo, and is a biomarker for human aging in vivo,53
immunohistochemical staining of p16 could be used in
studies of skin aging.
To determine the function of moesin, experimental
methods could involve the suppression or overexpression
of moesin. However, since the overexpression of moesin is
anticipated to be associated with oncogenesis in addition to
anti-aging, the effect of moesin suppression on the aging
of cells was investigated first. We postulate that the selec-
tive suppression of moesin in cancer cells may have an
anti-cancer effect; indeed, moesin expression is enhanced
in cancer cells and it has been suggested as a potential
prognostic and diagnostic marker of renal cell carcino-
ma.30,54,55 In addition, moesin-knock-down with shRNA has
been reported to induce the apoptosis of teratocarcinoma
cells.34 Therefore, the possibility of tumor development via
moesin overexpression should be examined in future ex-
periments.
Our study showed that the signs of cellular senescence
appeared early with moesin knock-down, and that cell
cycle arrest occurred on inducing the increased expression
of p16. Moesin was postulated to influence cell senes-
cence, and it should be a useful marker for cell senescence,
as well as for evaluating the level of aging. If the accele-
ration of aging were proven in a moesin knock-down
animal model, it could be a breakthrough model for aging
experiments, and could be used to validate the efficacy of
anti-aging treatments. Furthermore, it could be very useful
to studies on the pathophysiological mechanism of various
diseases of aging, as long as the factors and mechanisms
influencing moesin expression can be determined.
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